BackRapport Therapeutics Overview
Rapport Therapeutics Inc.

Rapport Therapeutics Target Price

Analysts' 12-month price predictions for RAPP.

Get informed when a big investor buys or sells

+ Follow

Share Price

$41.46

Average Target Price

$59.7544.1% upside

4 analysts in the last 4 months

High: $66 | Low: $52

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-24Leerink Partners$5225.4% upsideOpen
2026-05-21BTIG$6556.8% upsideOpen
2026-05-18Truist Financial$5635.1% upsideOpen
2026-04-10Raymond JamesTiago Fauth$6659.2% upsideOpen
2026-03-09BTIGKambiz Yazdi$4713.4% upsideOpen
2026-02-02Wells FargoBenjamin Burnett$433.7% upsideOpen
2025-12-19Wells Fargo$5123% upsideOpen
2025-12-09H.C. WainwrightDouglas Tsao$403.5% downsideOpen
2025-09-16Truist FinancialJoon Lee$446.1% upsideOpen
2024-07-02JefferiesAndrew Tsai$3515.6% downsideOpen
2024-07-02Stifel NicolausPaul Matteis$3515.6% downsideOpen